Identifying Meibomian Gland Dysfunction Biomarkers in a Cohort of Patients Affected by DM Type II

Identifying Meibomian Gland Dysfunction Biomarkers in a Cohort of Patients Affected by DM Type II

(1) Background: Meibomian gland dysfunction (MGD) among patients with diabetes mellitus (DM) is a common manifestation of dry eye syndrome (DES). (2) Methods: The purpose of this study is to identify clinical parameters and biomarkers useful to improve the follow-up and the treatment of these patien...

Full description

Bibliographic Details
Main Authors: Alessandro Abbouda, Antonio Florido, Filippo Avogaro, John Bladen, Enzo Maria Vingolo
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Vision
Subjects:
mibomian gland dysfunction
diabetes mellitus
hormones
biomarkers
Online Access:https://www.mdpi.com/2411-5150/7/2/28

Internet

https://www.mdpi.com/2411-5150/7/2/28

Similar Items